Institutional members access full text with Ovid®

Share this article on:

Development of phosphodiesterase-1 inhibitors for negative symptoms of schizophrenia

Wennogle, Lawrence; Davis, Robert; Vanover, Kimberly; Snyder, Gretchen; Hendrick, Joseph; Li, Peng; Fienberg, Allen; Mates, Sharon

International Clinical Psychopharmacology: September 2011 - Volume 26 - Issue - p e51–e52
doi: 10.1097/01.yic.0000405720.93146.2c
The 15th Biennial Winter Workshop in Psychoses, 15–18 November 2009, Barcelona, Spain: Oral Platform Presentations
© 2011 Lippincott Williams & Wilkins, Inc.